US BANCORP \DE\ - ZEALAND PHARMA A S ownership

ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 20 filers reported holding ZEALAND PHARMA A S in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ZEALAND PHARMA A S
ValueSharesWeighting
Q2 2022$7,000
-12.5%
5090.0%0.00%
Q1 2022$8,000
-33.3%
509
-7.3%
0.00%
Q4 2021$12,000
-29.4%
549
-2.1%
0.00%
Q3 2021$17,0000.0%561
-1.8%
0.00%
Q2 2021$17,000
+142.9%
571
+158.4%
0.00%
Q1 2021$7,0000.0%221
+3.3%
0.00%
Q4 2020$7,000
-30.0%
214
-17.7%
0.00%
Q3 2020$10,000
+11.1%
2600.0%0.00%
Q2 2020$9,000
+12.5%
260
+9.7%
0.00%
Q1 2020$8,0002370.00%
Other shareholders
ZEALAND PHARMA A S shareholders Q1 2020
NameSharesValueWeighting ↓
FARALLON CAPITAL MANAGEMENT LLC 750,000$25,875,0000.22%
AWM Investment Company, Inc. 19,981$689,0000.18%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 5,653$183,0000.08%
OLD MISSION CAPITAL LLC 15,890$548,0000.05%
WELLINGTON MANAGEMENT GROUP LLP 1,433,091$49,442,0000.01%
ROYCE & ASSOCIATES LP 10,000$345,0000.01%
STATE OF WISCONSIN INVESTMENT BOARD 44,092$1,521,0000.01%
Rockefeller Capital Management L.P. 8,876$306,0000.00%
Winslow, Evans & Crocker, Inc. 236$10,0000.00%
Filbrandt Wealth Management, LLC 25$1,0000.00%
View complete list of ZEALAND PHARMA A S shareholders